Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jun 20;40(18):1967-1970.
doi: 10.1200/JCO.22.00274. Epub 2022 Apr 21.

For Head and Neck Cancer, It Is Still Cisplatin, But How Much, How Often, and How Tolerable? New Randomized Phase III Data For the Adjuvant Setting

D Neil Hayes  1 , John Patrick Gleysteen  1   2 , David Louis Schwartz  1   3
Affiliations
Editorial

For Head and Neck Cancer, It Is Still Cisplatin, But How Much, How Often, and How Tolerable? New Randomized Phase III Data For the Adjuvant Setting

D Neil Hayes et al. J Clin Oncol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

D. Neil HayesLeadership: GeneCentricStock and Other Ownership Interests: GeneCentricConsulting or Advisory Role: GeneCentric, Merck, Turnstone BioPatents, Royalties, Other Intellectual Property: I hold several diagnostic patents or pending patents in the area of solid tumor diagnostics John Patrick GleysteenConsulting or Advisory Role: Zimmer BioMet David Louis SchwartzResearch Funding: National Cancer Institute, Elekta (Inst)Other Relationship: National Comprehensive Cancer Network, NRG Cooperative Research GroupNo other potential conflicts of interest were reported.

Figures

FIG 1.
FIG 1.
Designs of the (A) JCOG-1008 trial and the (B) HN009 trial. AJCC, American Joint Committee on Cancer; CDDP, cisplatin; RT, radiotherapy; SCCHN, squamous cell carcinoma of the head and neck.
See this image and copyright information in PMC

Comment on

References

    1. Connell PP, Hellman S.Advances in radiotherapy and implications for the next century: A historical perspective Cancer Res 69383–3922009 - PubMed
    1. Saunders MI, Rojas AM.Management of cancer of the head and neck—A cocktail with your PORT? N Engl J Med 3501997–19992004 - PubMed
    1. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer N Engl J Med 3501945–19522004 - PubMed
    1. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck N Engl J Med 3501937–19442004 - PubMed
    1. Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501) Head Neck 27843–8502005 - PubMed

MeSH terms

LinkOut - more resources